Results 11 to 20 of about 51,365 (299)

Quality of Life Assessment after Pancreatic Enzyme Replacement Therapy in Chronic Pancreatitis [PDF]

open access: yesCanadian Journal of Gastroenterology, 2003
GOALS: To evaluate the quality of life (QoL) of patients with chronic pancreatitis before and after pancreatic enzyme replacement therapy in a prospective, multicentre, follow-up study.
László Czakó   +8 more
doaj   +3 more sources

Enzyme replacement therapy for pancreatic insufficiency: present and future

open access: yesClinical and Experimental Gastroenterology, 2011
Aaron Fieker1, Jessica Philpott1, Martine Armand21Division of Digestive Diseases, University of Oklahoma, OKC, OK, USA; 2INSERM, U476 "Nutrition Humaine et Lipides", Marseille, F-13385 France; Univ Méditerranée Aix-
Fieker A, Philpott J, Arm, M
doaj   +5 more sources

Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis. [PDF]

open access: yesNutrients, 2022
While typically considered a pulmonary disease, cystic fibrosis patients develop significant nutritional complications and comorbidities, especially those who are pancreatic insufficient. Clinicians must have a high suspicion for cystic fibrosis among patients with clinical symptoms of pancreatic insufficiency, and pancreatic enzymatic replacement ...
Freswick PN, Reid EK, Mascarenhas MR.
europepmc   +3 more sources

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer. [PDF]

open access: yesCancers (Basel), 2020
Pancreatic cancer is an aggressive malignancy and the seventh leading cause of global cancer deaths in industrialised countries. More than 80% of patients suffer from significant weight loss at diagnosis and over time tend to develop severe cachexia. A major cause of weight loss is malnutrition. Patients may experience pancreatic exocrine insufficiency
Pezzilli R   +5 more
europepmc   +4 more sources

Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis. [PDF]

open access: yesCochrane Database Syst Rev, 2021
Cystic fibrosis (CF) is an autosomal recessive, life-limiting, multisystem disease affecting over 70,000 individuals worldwide. Between 80% and 90% of people with CF suffer with pancreatic exocrine insufficiency, which if left untreated, leads to a poor nutritional status.
Ng C, Major G, Smyth AR.
europepmc   +3 more sources

Pancreatic exocrine insufficiency in diabetes mellitus

open access: yesСахарный диабет, 2023
Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes and affect not only the quality, but also life expectancy. At the same time, the diagnosis and
M. V. Shestakova   +10 more
doaj   +1 more source

Pancreatic exocrine insufficiency after bariatric surgery [PDF]

open access: yes, 2017
Morbid obesity is a lifelong disease, and all patients require complementary follow-up including nutritional surveillance by a multidisciplinary team after bariatric procedures.
Arnelo, Urban   +7 more
core   +1 more source

Secondary exocrine pancreatic insufficiency. Features of the choice of the enzyme

open access: yesМедицинский совет, 2021
Exocrine pancreatic insufficiency is quite common in clinical practice of doctors of many specialties. Decrease in intraduodenal lipase levels below 5–10% of normal leads to pancreatic steatorrhea, weight loss and a potential decrease in quality of life.
I. G. Pakhomova
doaj   +1 more source

Role of Fibre in Nutritional Management of Pancreatic Diseases [PDF]

open access: yes, 2019
The role of fibre intake in the management of patients with pancreatic disease is still controversial. In acute pancreatitis, a prebiotic enriched diet is associated with low rates of pancreatic necrosis infection, hospital stay, systemic inflammatory ...
Badiali, Danilo   +7 more
core   +1 more source

Staging chronic pancreatitis with exocrine function tests: Are we better? [PDF]

open access: yes, 2017
Chronic pancreatitis (CP) is an inflammatory disease of the pancreas evolving in progressive fibrotic disruption of the gland with exocrine and endocrine pancreatic insufficiency.
MOLETTA, LUCIA, SPERTI, COSIMO
core   +1 more source

Home - About - Disclaimer - Privacy